Cost-Effetivess of Routine Low Molecular Weight Heparin DVT Prophylaxis Following Seelct Foot and Ankle Surgeries | ||
|
Start Date: 04/27/2017 Time: 02:30 PM -
03:00 PM Room: Track: Doctor's Track 2 Speaker/s: Adam Fleischer Moderator: Description: In this session, the authors explore the impact on US health systems when providers routinely provide low molecular weight heparin DVT prophylaxis for "high risk" foot/ankle surgeries. Learning Objectives: * Describe the short-term impact on US health systems of policies that favor routine DVT prophylaxis with LMWH. * Describe the long-term impact on US health systems of policies that favor routine prophylaxis with LMWH. * Describe the American Board of Internal Medicine's "Choosing Wisely" campaign and what is says about routine use of LMWH in foot/ankle surgery. |
||
|